newsfilter
← Latest News
Business Wire·

AbCellera's Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit

The Federal Circuit rejects Bruker Cellular's invalidity challenge to AbCellera's patent for microfluidic devices and their use in culturing cells AbCellera (NASDAQ:ABCL) today announced that the United States Court of